Pancreatic Cancer Research

ResearcherHarvard UniversityActive in the last 2 years

Avinash R. Kambadakone

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6714-9190; OpenAlex author ID A5018337325, A5043080895. Sources: OpenAlex.

Their work

Papers
34 (first author 1, last author 11)
Trials
0
Grants
0
Labs led
1
Collaborators
120
Papers, trials and grants by year

2018: 4 papers · 2019: none · 2020: 3 papers · 2021: 3 papers · 2022: 7 papers · 2023: 3 papers · 2024: 4 papers · 2025: 3 papers · 2026: 7 papers

Papers 34

  1. Pancreatic Cancer Risk in Patients With Low-Risk Cystic Lesions. Co-author DOI 10.1001/jamanetworkopen.2026.13808↗
  2. Novel silicon-based material decomposition images in diagnosis of pancreatic ductal adenocarcinoma: comparison with iodine-based and 50-keV virtual monoenerget… Co-author DOI 10.1007/s11604-025-01856-9↗
  3. Pancreatic Cancer Screening and Early Detection: Current Strategies and Emerging Innovations in Imaging. Last author DOI 10.1016/j.rcl.2026.01.005↗
  4. Artificial intelligence and radiologists in pancreatic cancer detection using standard of care CT scans (PANORAMA): an international, paired, non-inferiority, … Co-author DOI 10.1016/s1470-2045(25)00567-4↗
  5. Heuriskance: a novel paradigm for systematic earlier detection of sporadic pancreatic cancer. Co-author DOI 10.1093/jnci/djaf291↗
  6. Disparities in the diagnosis and management of exocrine pancreatic insufficiency in resectable vs metastatic pancreatic cancer. Co-author DOI 10.1093/oncolo/oyag084↗
  7. Pancreatic Cancer Screening and Early Detection: Where Are We Now? Last author DOI 10.1148/rg.250146↗
  8. Best Practices for Delivering Neoadjuvant Therapy in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1001/jamasurg.2024.5191↗
  9. Advancements in early detection of pancreatic cancer: the role of artificial intelligence and novel imaging techniques. Co-author DOI 10.1007/s00261-024-04644-7↗
  10. Factors Associated With Aborted Whipple Procedures for Periampullary Carcinoma: A Multicenter Case-Control Study by the SAR Pancreatic Ductal Adenocarcinoma Di… Co-author DOI 10.2214/ajr.24.32160↗
  11. Pancreatic cancer detection with dual-energy CT: diagnostic performance of 40 keV and 70 keV virtual monoenergetic images. Co-author DOI 10.1007/s11547-024-01806-x↗
  12. Does CT overestimate extra-pancreatic perineural invasion in patients with pancreatic ductal adenocarcinoma following neoadjuvant chemoradiation therapy? Last author DOI 10.1093/bjr/tqae001↗
  13. Large Language Models for Automated Synoptic Reports and Resectability Categorization in Pancreatic Cancer. Co-author DOI 10.1148/radiol.233117↗
  14. Imaging for Early Detection of Pancreatic Ductal Adenocarcinoma: Updates and Challenges in the Implementation of Screening and Surveillance Programs. Co-author DOI 10.2214/ajr.24.31151↗
  15. Postoperative surveillance of pancreatic ductal adenocarcinoma (PDAC) recurrence: practice pattern on standardized imaging and reporting from the society of ab… Co-author DOI 10.1007/s00261-022-03693-0↗
  16. Determination of arterial invasion in pancreatic ductal adenocarcinoma: what is the best diagnostic criterion on CT? Co-author DOI 10.1007/s00330-023-09521-3↗
  17. MRI-Based Tumor Necrosis Depiction in Pancreatic Ductal Adenocarcinoma: Can It Predict Tumor Aggressiveness? Last author DOI 10.3390/cancers15082313↗
  18. Vascular involvement and resectability of pancreatic ductal adenocarcinoma on contrast-enhanced MRI: comparison with pancreatic protocol CT. Co-author DOI 10.1007/s00261-022-03581-7↗
  19. Arterial involvement and resectability scoring system to predict R0 resection in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant chemor… Last author DOI 10.1007/s00330-021-08304-y↗
  20. Early Detection Initiative: A randomized controlled trial of algorithm-based screening in patients with new onset hyperglycemia and diabetes for early detectio… Co-author DOI 10.1016/j.cct.2021.106659↗
  21. Concordance of EUS and MRI/MRCP findings among high-risk individuals undergoing pancreatic cancer screening. Co-author DOI 10.1016/j.pan.2022.07.015↗
  22. Prediction of R Status in Resections for Pancreatic Cancer Using Simplified Radiological Criteria. Co-author DOI 10.1097/sla.0000000000005433↗
  23. Prediction of overall survival in patients with pancreatic ductal adenocarcinoma: histogram analysis of ADC value and correlation with pathological intratumora… Co-author DOI 10.1186/s12880-022-00751-3↗
  24. Standardization of MRI Screening and Reporting in Individuals With Elevated Risk of Pancreatic Ductal Adenocarcinoma: Consensus Statement of the PRECEDE Consor… Co-author DOI 10.2214/ajr.22.27859↗
  25. Simulated twin-phase pancreatic CT generated using single portal venous phase dual-energy CT acquisition in pancreatic ductal adenocarcinoma. Last author DOI 10.1007/s00261-020-02921-9↗
  26. Hepatobiliary contrast uptake patterns on gadoxetic acid-enhanced MRI in liver metastases from pancreatic ductal adenocarcinoma: can it predict prognosis? Last author DOI 10.1007/s00330-020-07115-x↗
  27. Radiomics for CT Assessment of Vascular Contact in Pancreatic Adenocarcinoma. First author DOI 10.1148/radiol.2021211635↗
  28. White paper on pancreatic ductal adenocarcinoma from society of abdominal radiology's disease-focused panel for pancreatic ductal adenocarcinoma: Part I, AJCC … Co-author DOI 10.1007/s00261-019-02289-5↗
  29. White paper on pancreatic ductal adenocarcinoma from society of abdominal radiology's disease-focused panel for pancreatic ductal adenocarcinoma: Part II, upda… Last author DOI 10.1007/s00261-019-02290-y↗
  30. Therapeutic response assessment in pancreatic ductal adenocarcinoma: society of abdominal radiology review paper on the role of morphological and functional im… Last author DOI 10.1007/s00261-020-02723-z↗
  31. Pancreatic adenocarcinoma: cross-sectional imaging techniques. Last author DOI 10.1007/s00261-017-1380-4↗
  32. Role of rapid kV-switching dual-energy CT in assessment of post-surgical local recurrence of pancreatic adenocarcinoma. Co-author DOI 10.1007/s00261-017-1390-2↗
  33. Multi-institutional survey on imaging practice patterns in pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s00261-017-1433-8↗
  34. Response assessment in pancreatic ductal adenocarcinoma: role of imaging. Last author DOI 10.1007/s00261-017-1434-7↗

Closest collaborators

The 25 strongest of 120 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yoshifumi Noda · 11 shared papers, 2021–2026 · strength 2.20
  2. Elizabeth M. Hecht · 8 shared papers, 2020–2026 · strength 1.35
  3. Zhen J. Wang · 7 shared papers, 2020–2026 · strength 1.14
  4. Ajit Harishkumar Goenka · 6 shared papers, 2020–2026 · strength 1.11
  5. Chenchan Huang · 5 shared papers, 2022–2026 · strength 1.04
  6. Erik V. Soloff · 8 shared papers, 2018–2025 · strength 0.94
  7. Masayuki Matsuo · 5 shared papers, 2022–2026 · strength 0.92
  8. Shravya Srinivas Rao · 3 shared papers, 2024–2026 · strength 0.89
  9. Anushri Parakh · 5 shared papers, 2018–2024 · strength 0.79
  10. Samuel Joseph Galgano · 4 shared papers, 2023–2025 · strength 0.74
  11. Suresh T. Chari · 3 shared papers, 2022–2026 · strength 0.73
  12. Richard Kinh Gian · 4 shared papers, 2020–2025 · strength 0.67
  13. Priya Bhosale · 6 shared papers, 2018–2024 · strength 0.67
  14. Michael Hayden Rosenthal · 3 shared papers, 2023–2026 · strength 0.66
  15. Lyndon Luk · 4 shared papers, 2022–2025 · strength 0.61
  16. Naveen M. Kulkarni · 5 shared papers, 2018–2024 · strength 0.60
  17. Anirban Maitra · 3 shared papers, 2022–2026 · strength 0.60
  18. Marc Zins · 5 shared papers, 2020–2025 · strength 0.58
  19. Yasmin Genevieve Hernandez-Barco · 2 shared papers, 2026 · strength 0.57
  20. Linda Chi Hang Chu · 3 shared papers, 2023–2025 · strength 0.56
  21. Carlos F. Fernandez-del Castillo · 3 shared papers, 2022–2026 · strength 0.54
  22. Eric Peter Tamm · 5 shared papers, 2018–2023 · strength 0.49
  23. Joy Liau · 3 shared papers, 2022–2025 · strength 0.48
  24. Vinit Baliyan · 3 shared papers, 2018–2023 · strength 0.48
  25. Atif Zaheer · 4 shared papers, 2018–2025 · strength 0.47

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.